[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biologics Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

February 2023 | 100 pages | ID: GEA29ECD7F12EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Biologics contract manufacturing organizations offer all services right from research and development to dosage preparation and packaging under one roof. Therefore, this factor serves to be an important growth indicator for the biologics contract manufacturing market.

According to our (Global Info Research) latest study, the global Biologics Contract Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Biologics Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Biologics Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2018-2029

Global Biologics Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Biologics Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Biologics Contract Manufacturing market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Biologics Contract Manufacturing

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Biologics Contract Manufacturing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim GmbH and Lonza, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Biologics Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • MABs
  • Recombinant Protein
  • Others
Market segment by Application
  • Oncology
  • Immunological Disorders
  • Cardiovascular Disorders (CVDs)
  • Hematological Disorders
  • Others
Market segment by players, this report covers
  • Wuxi Biologics
  • Abzena Ltd.
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Boehringer Ingelheim GmbH
  • Lonza
  • SamsungBiologics
  • Abbvie
  • Catalent
  • Bioreliance
  • Thermo Fischer (Patheon)
  • Eurofins CDMO
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Biologics Contract Manufacturing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Biologics Contract Manufacturing, with revenue, gross margin and global market share of Biologics Contract Manufacturing from 2018 to 2023.

Chapter 3, the Biologics Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biologics Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics Contract Manufacturing.

Chapter 13, to describe Biologics Contract Manufacturing research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Biologics Contract Manufacturing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologics Contract Manufacturing by Type
  1.3.1 Overview: Global Biologics Contract Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Global Biologics Contract Manufacturing Consumption Value Market Share by Type in 2022
  1.3.3 MABs
  1.3.4 Recombinant Protein
  1.3.5 Others
1.4 Global Biologics Contract Manufacturing Market by Application
  1.4.1 Overview: Global Biologics Contract Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Oncology
  1.4.3 Immunological Disorders
  1.4.4 Cardiovascular Disorders (CVDs)
  1.4.5 Hematological Disorders
  1.4.6 Others
1.5 Global Biologics Contract Manufacturing Market Size & Forecast
1.6 Global Biologics Contract Manufacturing Market Size and Forecast by Region
  1.6.1 Global Biologics Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
  1.6.2 Global Biologics Contract Manufacturing Market Size by Region, (2018-2029)
  1.6.3 North America Biologics Contract Manufacturing Market Size and Prospect (2018-2029)
  1.6.4 Europe Biologics Contract Manufacturing Market Size and Prospect (2018-2029)
  1.6.5 Asia-Pacific Biologics Contract Manufacturing Market Size and Prospect (2018-2029)
  1.6.6 South America Biologics Contract Manufacturing Market Size and Prospect (2018-2029)
  1.6.7 Middle East and Africa Biologics Contract Manufacturing Market Size and Prospect (2018-2029)

2 COMPANY PROFILES

2.1 Wuxi Biologics
  2.1.1 Wuxi Biologics Details
  2.1.2 Wuxi Biologics Major Business
  2.1.3 Wuxi Biologics Biologics Contract Manufacturing Product and Solutions
  2.1.4 Wuxi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Wuxi Biologics Recent Developments and Future Plans
2.2 Abzena Ltd.
  2.2.1 Abzena Ltd. Details
  2.2.2 Abzena Ltd. Major Business
  2.2.3 Abzena Ltd. Biologics Contract Manufacturing Product and Solutions
  2.2.4 Abzena Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Abzena Ltd. Recent Developments and Future Plans
2.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  2.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Details
  2.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Major Business
  2.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product and Solutions
  2.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments and Future Plans
2.4 Boehringer Ingelheim GmbH
  2.4.1 Boehringer Ingelheim GmbH Details
  2.4.2 Boehringer Ingelheim GmbH Major Business
  2.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product and Solutions
  2.4.4 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.5 Lonza
  2.5.1 Lonza Details
  2.5.2 Lonza Major Business
  2.5.3 Lonza Biologics Contract Manufacturing Product and Solutions
  2.5.4 Lonza Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Lonza Recent Developments and Future Plans
2.6 SamsungBiologics
  2.6.1 SamsungBiologics Details
  2.6.2 SamsungBiologics Major Business
  2.6.3 SamsungBiologics Biologics Contract Manufacturing Product and Solutions
  2.6.4 SamsungBiologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 SamsungBiologics Recent Developments and Future Plans
2.7 Abbvie
  2.7.1 Abbvie Details
  2.7.2 Abbvie Major Business
  2.7.3 Abbvie Biologics Contract Manufacturing Product and Solutions
  2.7.4 Abbvie Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Abbvie Recent Developments and Future Plans
2.8 Catalent
  2.8.1 Catalent Details
  2.8.2 Catalent Major Business
  2.8.3 Catalent Biologics Contract Manufacturing Product and Solutions
  2.8.4 Catalent Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Catalent Recent Developments and Future Plans
2.9 Bioreliance
  2.9.1 Bioreliance Details
  2.9.2 Bioreliance Major Business
  2.9.3 Bioreliance Biologics Contract Manufacturing Product and Solutions
  2.9.4 Bioreliance Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Bioreliance Recent Developments and Future Plans
2.10 Thermo Fischer (Patheon)
  2.10.1 Thermo Fischer (Patheon) Details
  2.10.2 Thermo Fischer (Patheon) Major Business
  2.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Product and Solutions
  2.10.4 Thermo Fischer (Patheon) Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Thermo Fischer (Patheon) Recent Developments and Future Plans
2.11 Eurofins CDMO
  2.11.1 Eurofins CDMO Details
  2.11.2 Eurofins CDMO Major Business
  2.11.3 Eurofins CDMO Biologics Contract Manufacturing Product and Solutions
  2.11.4 Eurofins CDMO Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Eurofins CDMO Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Biologics Contract Manufacturing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
  3.2.1 Market Share of Biologics Contract Manufacturing by Company Revenue
  3.2.2 Top 3 Biologics Contract Manufacturing Players Market Share in 2022
  3.2.3 Top 6 Biologics Contract Manufacturing Players Market Share in 2022
3.3 Biologics Contract Manufacturing Market: Overall Company Footprint Analysis
  3.3.1 Biologics Contract Manufacturing Market: Region Footprint
  3.3.2 Biologics Contract Manufacturing Market: Company Product Type Footprint
  3.3.3 Biologics Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Biologics Contract Manufacturing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biologics Contract Manufacturing Market Forecast by Type (2024-2029)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2023)
5.2 Global Biologics Contract Manufacturing Market Forecast by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
6.2 North America Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
6.3 North America Biologics Contract Manufacturing Market Size by Country
  6.3.1 North America Biologics Contract Manufacturing Consumption Value by Country (2018-2029)
  6.3.2 United States Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  6.3.3 Canada Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  6.3.4 Mexico Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

7 EUROPE

7.1 Europe Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
7.2 Europe Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
7.3 Europe Biologics Contract Manufacturing Market Size by Country
  7.3.1 Europe Biologics Contract Manufacturing Consumption Value by Country (2018-2029)
  7.3.2 Germany Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  7.3.3 France Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  7.3.4 United Kingdom Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  7.3.5 Russia Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  7.3.6 Italy Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

8 ASIA-PACIFIC

8.1 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biologics Contract Manufacturing Market Size by Region
  8.3.1 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2018-2029)
  8.3.2 China Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.3 Japan Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.4 South Korea Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.5 India Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.6 Southeast Asia Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.7 Australia Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

9 SOUTH AMERICA

9.1 South America Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
9.2 South America Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
9.3 South America Biologics Contract Manufacturing Market Size by Country
  9.3.1 South America Biologics Contract Manufacturing Consumption Value by Country (2018-2029)
  9.3.2 Brazil Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  9.3.3 Argentina Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Country
  10.3.1 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2018-2029)
  10.3.2 Turkey Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  10.3.3 Saudi Arabia Biologics Contract Manufacturing Market Size and Forecast (2018-2029)
  10.3.4 UAE Biologics Contract Manufacturing Market Size and Forecast (2018-2029)

11 MARKET DYNAMICS

11.1 Biologics Contract Manufacturing Market Drivers
11.2 Biologics Contract Manufacturing Market Restraints
11.3 Biologics Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
  11.5.1 Influence of COVID-19
  11.5.2 Influence of Russia-Ukraine War

12 INDUSTRY CHAIN ANALYSIS

12.1 Biologics Contract Manufacturing Industry Chain
12.2 Biologics Contract Manufacturing Upstream Analysis
12.3 Biologics Contract Manufacturing Midstream Analysis
12.4 Biologics Contract Manufacturing Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Biologics Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biologics Contract Manufacturing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biologics Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biologics Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Wuxi Biologics Company Information, Head Office, and Major Competitors
Table 6. Wuxi Biologics Major Business
Table 7. Wuxi Biologics Biologics Contract Manufacturing Product and Solutions
Table 8. Wuxi Biologics Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Wuxi Biologics Recent Developments and Future Plans
Table 10. Abzena Ltd. Company Information, Head Office, and Major Competitors
Table 11. Abzena Ltd. Major Business
Table 12. Abzena Ltd. Biologics Contract Manufacturing Product and Solutions
Table 13. Abzena Ltd. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abzena Ltd. Recent Developments and Future Plans
Table 15. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Information, Head Office, and Major Competitors
Table 16. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Major Business
Table 17. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Product and Solutions
Table 18. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments and Future Plans
Table 20. Boehringer Ingelheim GmbH Company Information, Head Office, and Major Competitors
Table 21. Boehringer Ingelheim GmbH Major Business
Table 22. Boehringer Ingelheim GmbH Biologics Contract Manufacturing Product and Solutions
Table 23. Boehringer Ingelheim GmbH Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Table 25. Lonza Company Information, Head Office, and Major Competitors
Table 26. Lonza Major Business
Table 27. Lonza Biologics Contract Manufacturing Product and Solutions
Table 28. Lonza Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Lonza Recent Developments and Future Plans
Table 30. SamsungBiologics Company Information, Head Office, and Major Competitors
Table 31. SamsungBiologics Major Business
Table 32. SamsungBiologics Biologics Contract Manufacturing Product and Solutions
Table 33. SamsungBiologics Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. SamsungBiologics Recent Developments and Future Plans
Table 35. Abbvie Company Information, Head Office, and Major Competitors
Table 36. Abbvie Major Business
Table 37. Abbvie Biologics Contract Manufacturing Product and Solutions
Table 38. Abbvie Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Abbvie Recent Developments and Future Plans
Table 40. Catalent Company Information, Head Office, and Major Competitors
Table 41. Catalent Major Business
Table 42. Catalent Biologics Contract Manufacturing Product and Solutions
Table 43. Catalent Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Catalent Recent Developments and Future Plans
Table 45. Bioreliance Company Information, Head Office, and Major Competitors
Table 46. Bioreliance Major Business
Table 47. Bioreliance Biologics Contract Manufacturing Product and Solutions
Table 48. Bioreliance Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bioreliance Recent Developments and Future Plans
Table 50. Thermo Fischer (Patheon) Company Information, Head Office, and Major Competitors
Table 51. Thermo Fischer (Patheon) Major Business
Table 52. Thermo Fischer (Patheon) Biologics Contract Manufacturing Product and Solutions
Table 53. Thermo Fischer (Patheon) Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Thermo Fischer (Patheon) Recent Developments and Future Plans
Table 55. Eurofins CDMO Company Information, Head Office, and Major Competitors
Table 56. Eurofins CDMO Major Business
Table 57. Eurofins CDMO Biologics Contract Manufacturing Product and Solutions
Table 58. Eurofins CDMO Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Eurofins CDMO Recent Developments and Future Plans
Table 60. Global Biologics Contract Manufacturing Revenue (USD Million) by Players (2018-2023)
Table 61. Global Biologics Contract Manufacturing Revenue Share by Players (2018-2023)
Table 62. Breakdown of Biologics Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Biologics Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Biologics Contract Manufacturing Players
Table 65. Biologics Contract Manufacturing Market: Company Product Type Footprint
Table 66. Biologics Contract Manufacturing Market: Company Product Application Footprint
Table 67. Biologics Contract Manufacturing New Market Entrants and Barriers to Market Entry
Table 68. Biologics Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Biologics Contract Manufacturing Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Biologics Contract Manufacturing Consumption Value Share by Type (2018-2023)
Table 71. Global Biologics Contract Manufacturing Consumption Value Forecast by Type (2024-2029)
Table 72. Global Biologics Contract Manufacturing Consumption Value by Application (2018-2023)
Table 73. Global Biologics Contract Manufacturing Consumption Value Forecast by Application (2024-2029)
Table 74. North America Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Biologics Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Biologics Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Biologics Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Biologics Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Biologics Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Biologics Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Biologics Contract Manufacturing Raw Material
Table 105. Key Suppliers of Biologics Contract Manufacturing Raw Materials

LIST OF FIGURES

Figure 1. Biologics Contract Manufacturing Picture
Figure 2. Global Biologics Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biologics Contract Manufacturing Consumption Value Market Share by Type in 2022
Figure 4. MABs
Figure 5. Recombinant Protein
Figure 6. Others
Figure 7. Global Biologics Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Biologics Contract Manufacturing Consumption Value Market Share by Application in 2022
Figure 9. Oncology Picture
Figure 10. Immunological Disorders Picture
Figure 11. Cardiovascular Disorders (CVDs) Picture
Figure 12. Hematological Disorders Picture
Figure 13. Others Picture
Figure 14. Global Biologics Contract Manufacturing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Biologics Contract Manufacturing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Biologics Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Biologics Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Biologics Contract Manufacturing Consumption Value Market Share by Region in 2022
Figure 19. North America Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Biologics Contract Manufacturing Revenue Share by Players in 2022
Figure 25. Biologics Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Biologics Contract Manufacturing Market Share in 2022
Figure 27. Global Top 6 Players Biologics Contract Manufacturing Market Share in 2022
Figure 28. Global Biologics Contract Manufacturing Consumption Value Share by Type (2018-2023)
Figure 29. Global Biologics Contract Manufacturing Market Share Forecast by Type (2024-2029)
Figure 30. Global Biologics Contract Manufacturing Consumption Value Share by Application (2018-2023)
Figure 31. Global Biologics Contract Manufacturing Market Share Forecast by Application (2024-2029)
Figure 32. North America Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Biologics Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Biologics Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 42. France Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 49. China Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 52. India Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Biologics Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Biologics Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Biologics Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Biologics Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 66. Biologics Contract Manufacturing Market Drivers
Figure 67. Biologics Contract Manufacturing Market Restraints
Figure 68. Biologics Contract Manufacturing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Biologics Contract Manufacturing in 2022
Figure 71. Manufacturing Process Analysis of Biologics Contract Manufacturing
Figure 72. Biologics Contract Manufacturing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source


More Publications